$32.72
-1.99-5.75%
Last update: Oct 26, 12:49 PM
IDEAYA Biosciences Inc (IDYA) Stock Price, Quote, News & History
IDYANASDAQ
IDEAYA shares rise after darovasertib trial shows progression-free survival benefit in uveal melanoma; NDA filing planned for 2026.
You can purchase shares of IDEAYA Biosciences (NASDAQ:IDYA) through any online brokerage.
Other companies in IDEAYA Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
IDEAYA Biosciences has a consensus price target of $51.64.
The stock price for IDEAYA Biosciences (NASDAQ: IDYA) is $32.715 last updated October 26, 2026 at 12:49 PM EDT.
There are no upcoming dividends for IDEAYA Biosciences.
IDEAYA Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for IDEAYA Biosciences.
IDEAYA Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug...
